Januvia Gets Fast Start; Uptake Seen In Variety Of Diabetes Settings, Merck Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Company reports sales of $42 million for sitagliptin during the DPP-4 inhibitor's first quarter on the market.